Effects

If left untreated, the long-term effects of PNH can be serious and potentially life-threatening. Blood clots and kidney failure are two significant causes of death in people with PNH.3,13 In fact, venous or arterial thromboses account for approximately 40 percent to 67 percent of PNH-related deaths.3,12-15 Poor kidney function, or renal insufficiency, is six times more prevalent in patients with PNH than in the general population.16,17 Patients with PNH also suffer from severe quality-of-life issues, including severe fatigue, abdominal pain, difficulty swallowing, erectile dysfunction and poor cognitive function. These issues often force patients to modify their daily activity.6

Consequences of Hemolysis in PNH

Hemolysis in PNH


IMPORTANT SAFETY INFORMATION

Soliris increases the risk of meningococcal infections. Meningococcal infection may become rapidly life-threatening or fatal if not recognized and treated early

Soliris® increases the risk of meningococcal infections

  • Vaccinate patients with a meningococcal vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use
  • Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary

The effect of anticoagulant withdrawal during Soliris treatment has not been studied. Therefore, treatment with Soliris should not alter anticoagulant management.

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, a runny nose (nasopharyngitis), back pain, nausea, and tiredness (fatigue).